Belite Bio Target Price

Where could BLTE trade next? Consensus target price: $220.

Get informed when a big investor buys or sells

+ Follow

Share Price

$166.28

Average Target Price

$216.00

29.9% upside

2 analysts in the last 4 months

High: $217 | Low: $215

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-26	Mizuho SecuritiesGraig Suvannavejh	$215	29.3% upside
2026-05-22	Truist Financial	$217	30.5% upside
2026-03-04	H.C. WainwrightYi Chen	$200	20.3% upside
2026-03-03	Needham	$217	30.5% upside
2026-02-19	Mizuho SecuritiesGraig Suvannavejh	$223	34.1% upside
2026-01-06	Morgan Stanley	$191	14.9% upside
2025-12-03	BTIG	$187	12.5% upside
2025-12-02	Maxim Group	$200	20.3% upside
2025-12-02	Mizuho SecuritiesGraig Suvannavejh	$194	16.7% upside
2025-12-01	H.C. Wainwright	$185	11.3% upside
2025-11-20	Mizuho Securities	$105	36.9% downside
2024-08-13	H.C. WainwrightYi Chen	$60	63.9% downside

Belite Bio (BLTE) FAQ

Belite Bio (BLTE) currently reports a target price of $220. Use the charts on this page to explore Belite Bio's target price history and peer comparisons.

Analysts' average 12-month price target for Belite Bio is $220, about 29.9% upside from the current share price of $166.28. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $220, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Belite Bio, and consider following BLTE for alerts when major investors trade the stock.